New Buprenorphine and Naloxone Sublingual Film Indicated for The Treatment of Opioid Dependence

FDA approved Buprenorphine and Naloxone Sublingual film are available in 8 mg/2 mg and 12 mg/3 mg The prescription is limited to healthcare providers who meet certain qualifying requirements Should be used as part of a complete treatment plan to include counseling and psychosocial supportThis story is related to the following:Medicinal, Pharmaceutical& Nutraceutical Tablets
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news